Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.3.0.814
Consolidated Balance Sheets - USD ($)
Mar. 31, 2015
Dec. 31, 2014
Current Assets    
Cash and cash equivalents $ 3,171,530 $ 4,220,225
Restricted cash 325,341 325,181
Accounts receivable - project revenue and reimbursable project costs 318,383 469,086
Prepaid expenses and other current assets 319,494 205,185
Total Current Assets 4,134,748 5,219,677
Property Plant and Equipment -net 0 0
Other Assets    
Patent costs 852,862 833,560
Total Assets 4,987,610 6,053,237
Current Liabilities    
Accounts payable and accrued liabilities 586,685 653,669
Total Current Liabilities 586,685 653,669
Warrant liability 3,435,326 4,633,312
Total Liabilities $ 4,022,011 $ 5,286,981
Commitments and contingencies
Stockholders' Equity    
Preferred stock, $0.001 par value, 50,000,000 authorized shares, no shares issued and outstanding $ 0 $ 0
Common stock, $0.001 par value, 500,000,000 authorized, 18,082,874 shares outstanding at March 31, 2015 and December 31, 2014 18,083 18,083
Additional paid-in capital 70,883,145 70,801,464
Accumulated deficit (69,935,629) (70,053,291)
Total Stockholders' Equity 965,599 766,256
Total Liabilities and Stockholders' Equity $ 4,987,610 $ 6,053,237